Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. doctors group calls out CDC for 'confusing' isolation guidance

Published 01/05/2022, 02:44 PM
Updated 01/05/2022, 08:27 PM
© Reuters. People wait in line at a testing station for the coronavirus disease (COVID-19) at Cal State University San Marcos in San Marcos, California, U.S., January 5, 2022. REUTERS/Mike Blake

(Reuters) - The American Medical Association (AMA) on Wednesday criticized the government's guidelines on quarantine and isolation in the United States, saying the guidance was "confusing" and risked further spread of COVID-19.

On Tuesday, the U.S. Centers for Disease Control and Prevention (CDC) stopped short of recommending a rapid antigen test for people seeking to end their COVID-19 isolation at five days.

"A negative test should be required for ending isolation after one tests positive for COVID-19. Re-emerging without knowing one's status unnecessarily risks further transmission of the virus," the AMA said.

The CDC last week reduced the recommended isolation period for people with asymptomatic COVID to five days from 10, and on Tuesday backed that decision saying a review of 113 studies from 17 countries showed that most transmission occurs early in the course of infection.

The AMA said physicians are concerned that these recommendations put patients at risk and could further overwhelm the healthcare system.

© Reuters. People wait in line at a testing station for the coronavirus disease (COVID-19) at Cal State University San Marcos in San Marcos, California, U.S., January 5, 2022. REUTERS/Mike Blake

The Omicron variant of the coronavirus has spread rapidly across the United States, leading to a surge in hospitalizations and a shortage of test kits.

The AMA urged the U.S. government to use all means to ramp up production and distribution of COVID-19 tests, adding that a "dearth of tests at the moment does not justify omitting a testing requirement to exit a now shortened isolation".

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.